Published in Lancet on February 09, 2002
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A (2008) 4.74
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol (2010) 2.88
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer (2009) 2.77
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol (2011) 2.52
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis (2008) 1.70
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest (2012) 1.61
Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst (2015) 1.59
Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma. J Invest Dermatol (2013) 1.58
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer (2010) 1.53
Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol (2011) 1.46
The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol (2008) 1.43
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer (2010) 1.42
Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS (2009) 1.37
Merkel cell carcinoma. World J Surg Oncol (2006) 1.33
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol (2012) 1.30
Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol (2009) 1.28
Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol (2007) 1.27
Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology (2013) 1.27
Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol (2012) 1.14
MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol (2012) 1.14
Viruses and human cancer: from detection to causality. Cancer Lett (2010) 1.05
Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One (2009) 1.04
Does a new polyomavirus contribute to Merkel cell carcinoma? Genome Biol (2008) 1.03
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep (2011) 1.03
Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J Virol (2013) 1.01
Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma. J Invest Dermatol (2009) 1.01
Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog (2012) 1.01
Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis (2011) 0.99
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. J Virol Methods (2012) 0.96
Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status. J Skin Cancer (2012) 0.96
A technological update of molecular diagnostics for infectious diseases. Infect Disord Drug Targets (2008) 0.95
Chronic mTOR activation promotes cell survival in Merkel cell carcinoma. Cancer Lett (2013) 0.94
Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol (2014) 0.94
Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. Virology (2010) 0.93
Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients. Virol J (2011) 0.91
The role of the immune response in merkel cell carcinoma. Cancers (Basel) (2013) 0.91
Merkel cell polyomavirus small T antigen mRNA level is increased following in vivo UV-radiation. PLoS One (2010) 0.90
Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin Dev Immunol (2013) 0.89
Sustained remission of metastatic Merkel cell carcinoma with treatment of HIV infection. J R Soc Med (2003) 0.89
The conundrum of causality in tumor virology: the cases of KSHV and MCV. Semin Cancer Biol (2013) 0.89
Diversification and specialization of touch receptors in skin. Cold Spring Harb Perspect Med (2014) 0.88
Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005. J Am Acad Dermatol (2010) 0.88
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer (2013) 0.86
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. Br J Cancer (2012) 0.86
Merkel cell carcinoma in immunosuppressed patients. Cancers (Basel) (2014) 0.86
Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation (2013) 0.84
Frequent detection of Merkel cell polyomavirus DNA in sera of HIV-1-positive patients. Virol J (2013) 0.84
The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature. Front Oncol (2013) 0.84
Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor. PLoS One (2013) 0.83
Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer (2013) 0.83
Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int J Cancer (2012) 0.83
Merkel cell carcinoma. Am J Clin Oncol (2013) 0.83
Cancer risk in persons with HIV/AIDS in India: a review and future directions for research. Infect Agent Cancer (2009) 0.83
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol (2014) 0.83
Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw (2014) 0.82
Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker. Int J Clin Exp Pathol (2013) 0.82
Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. Wien Med Wochenschr (2013) 0.82
The concept of immune surveillance against tumors. The first theories. Oncotarget (2016) 0.80
Merkel cell carcinoma of the eyelid and periocular region. Cancers (Basel) (2014) 0.80
Merkel cell carcinoma associated with HIV: review of 14 patients. AIDS (2011) 0.80
Merkel cell carcinoma of skin-current controversies and recommendations. Rare Tumors (2011) 0.80
[Merkel cell carcinoma]. Pathologe (2014) 0.80
Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel) (2014) 0.80
Multiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982-2011. J Invest Dermatol (2014) 0.79
Digital Merkel cell carcinoma. Can J Plast Surg (2005) 0.79
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options. Onco Targets Ther (2015) 0.79
Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma. PLoS One (2012) 0.79
Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era. World J Virol (2015) 0.78
Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses (2015) 0.78
Merkel cell tumor of the skin treated with localized radiotherapy: are widely negative margins required? Rare Tumors (2011) 0.77
Merkel cell carcinoma of left groin: a case report and literature review. Case Rep Oncol Med (2013) 0.77
Cancer prevention in HIV-infected populations. Semin Oncol (2015) 0.77
Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon? Cancers (Basel) (2014) 0.77
Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma. Virchows Arch (2009) 0.77
Cells of origin and tumor-initiating cells for nonmelanoma skin cancers. Cancer Lett (2012) 0.77
Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiat Oncol (2012) 0.77
The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma. AIDS Res Treat (2012) 0.77
Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multi-modal tumor virus detection. J Invest Dermatol (2016) 0.77
Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. Br J Cancer (2014) 0.76
Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection. Cell Host Microbe (2016) 0.76
Merkel cell polyomavirus and Merkel cell carcinoma. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol (2011) 0.75
Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature. JAAD Case Rep (2015) 0.75
Common Commensal Cancer Viruses. PLoS Pathog (2017) 0.75
Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience. PLoS One (2015) 0.75
Nuclear medicine techniques in Merkel cell carcinoma: A case report and review of the literature. Oncol Lett (2015) 0.75
Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies. Cancers (Basel) (2014) 0.75
Merkel cell polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol (2016) 0.75
Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report. J Med Case Rep (2016) 0.75
Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. Cancer Res (2017) 0.75
Merkel cell carcinoma of the head and neck: emphasizing the risk of undertreatment. Eur Arch Otorhinolaryngol (2015) 0.75
Human oncogenic viruses: nature and discovery. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology (2012) 3.83
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56
AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood (2006) 2.90
Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med (2003) 2.81
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst (2011) 2.61
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Antibiotic use and inflammatory bowel diseases in childhood. Gut (2010) 2.48
Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis (2003) 2.42
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med (2010) 2.33
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer (2006) 2.25
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther (2006) 2.18
Moving forward in HIV-associated cancer. J Clin Oncol (2014) 2.14
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (2008) 2.14
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst (2003) 2.07
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog (2006) 2.06
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance. Gastroenterology (2006) 2.04
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis (2012) 2.01
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol (2010) 2.00
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97
Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96
Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut (2010) 1.94
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90
C-reactive protein and risk of lung cancer. J Clin Oncol (2010) 1.90
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis (2007) 1.88
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS (2014) 1.86
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol (2005) 1.84
HLA-Cw*04 and hepatitis C virus persistence. J Virol (2002) 1.83
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS (2003) 1.81
Hepatocellular carcinoma and other liver disease among Greenlanders chronically infected with hepatitis B virus: a population-based study. J Natl Cancer Inst (2011) 1.80
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology (2009) 1.80
Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis (2010) 1.78
The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol (2008) 1.74
APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis (2009) 1.74
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med (2004) 1.71
Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol (2008) 1.69
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis (2004) 1.69
Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67
Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr (2006) 1.66
Hepatitis C virus load and survival among injection drug users in the United States. Hepatology (2005) 1.66
Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS (2009) 1.64
Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis (2011) 1.62
Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut (2011) 1.62
Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis (2003) 1.62
Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer (2004) 1.61
Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A (2002) 1.61
Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol (2002) 1.59
Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst (2013) 1.59